The next big questions in cancer research
Cell · 2023-04 · 186 (8) · 1523-1527
DOI: 10.1016/j.cell.2023.01.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2023-04. Verfasst von Sherene Loi und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Neoplasms, Research Personnel. Die Arbeit wurde bisher 17-mal zitiert (Crossref).
Abstract (Originalsprache)
Our understanding of tumorigenesis and cancer progression as well as clinical therapies for different cancer types have evolved dramatically in recent years. However, even with this progress, there are big challenges for scientists and oncologists to tackle, ranging from unpacking the molecular and cellular mechanisms involved to therapeutics and biomarker development to quality of life in the aftermath of therapy. In this article, we asked researchers to comment on the questions that they think are important to address in the coming years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Loi, S., Settleman, J., Joyce, J. A., Pramesh, C. S., Bernards, R., Fan, J., Merchant, J. L., Moslehi, J., & Sellers, W. R. (2023). The next big questions in cancer research. Cell, 186(8), 1523-1527. https://doi.org/10.1016/j.cell.2023.01.037
Vancouver
Loi S, Settleman J, Joyce JA, Pramesh CS, Bernards R, Fan J, et al. The next big questions in cancer research. Cell. 2023;186(8):1523-1527. doi:10.1016/j.cell.2023.01.037
BibTeX
@article{Loi2023,
author = {Loi, Sherene and Settleman, Jeffrey and Joyce, Johanna A and Pramesh, C S and Bernards, Rene and Fan, Jia and Merchant, Juanita L and Moslehi, Javid and Sellers, William R},
title = {The next big questions in cancer research},
journal = {Cell},
year = {2023},
volume = {186},
number = {8},
pages = {1523--1527},
doi = {10.1016/j.cell.2023.01.037}
}
EUVIMED